Home / Inspections / 896197

FDA Inspection 896197 — Hikma Pharmaceuticals USA Inc.

Hikma Pharmaceuticals USA Inc. — FEI 2220525

The FDA completed an inspection of Hikma Pharmaceuticals USA Inc. on September 19, 2014 in Cherry Hill, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 19, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Unapproved and Misbranded Drugs
Location
Cherry Hill, NJ (United States)

Facility

Other inspections at this facility

  • 1304368 (NAI Wed May 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1237333 (VAI Wed Jun 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1222115 (VAI Fri Nov 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1176451 (NAI Thu Jul 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1106822 (VAI Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources